The Early Development Leader is accountable for strategically leading medicine development from Lead Optimization through Proof of Concept. They contribute to the development strategy, aligned with the Medicine Profile, with input from late-stage development, franchise commercial, and medical teams. The role involves making evidence-based decisions, engaging with the external community, and ensuring timely information exchange between GSK and external stakeholders. They also identify regulatory requirements and anticipate changes in the healthcare environment.